home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

302 rows where filing_period = "third_quarter", filing_year = 2024 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • MED · 302 ✖

filing_year 1

  • 2024 · 302 ✖

filing_period 1

  • third_quarter · 302 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
3198465 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) 9f6c2941-f6bb-4b8e-8133-4c462f5823e0 3T BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) 292538 SONIC HEALTHCARE USA 2024 third_quarter MED Issues relating to the regulation of laboratory developed tests, the VALID Act, issues relating to PAMA (the SALSA Bill), federal policies relating to the implementation of the anti-kickback requirements of the Support for Patients and Communities Act. Physician Lab Fee schedule. Anatomic Fee Schedule and Surprise Billing. COVID Testing and billing procedures. COVID Vaccine Federal Mandate. HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2024-07-18T11:27:57-04:00
3231516 HELIX, INC. c6b8757f-ac1a-469c-a23c-566a013a1d50 Q3 HELIX, INC. 401106164 HELIX, INC. 2024 third_quarter MED Oversight of Lab Developed Tests, express legislative authority. Expanded access to VAMC genetic and pharmacogemomic testing HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   80000 0 0 2024-09-30T10:22:47-04:00
3231552 AUBURN HEALTH STRATEGIES, LLC c7621dd5-467c-4527-9241-b3a4d0037ca9 Q3 AUBURN HEALTH STRATEGIES, LLC 292697 AMERICAN PROFICIENCY INSTITUTE 2024 third_quarter MED proficiency testing for clinical laboratories SENATE     0 0 2024-09-30T14:58:02-04:00
3231772 RAY C CULVER III 1ab267ff-7ee9-4374-b85b-53b2fbab81ea Q3 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2024 third_quarter MED Funding for USDA ARS human nutrition research in the FY2025 House and Senate Agriculture appropriation bills. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-10-01T16:20:09-04:00
3231947 MAGILL ASSOCIATES, LLC d8143dc3-1f32-4e0c-82e5-b4d6709c0fff Q3 MAGILL ASSOCIATES, LLC 401103511 THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES 2024 third_quarter MED FY 2025 appropriations for the development of a synthetic vaccine HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-10-02T11:25:44-04:00
3231998 HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. f3bbb9cd-039b-45b0-b193-b5a4e5c2e3b9 Q3 HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. 52925 HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. 2024 third_quarter MED HR 4534/S 2245 - Women and Lung Cancer Research and Preventative Services Act of 2023 All provisions This bill requires a review of women and lung cancer. HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2024-10-02T12:31:24-04:00
3232044 FLORIDA STATE UNIVERSITY 3d4d3fa4-784b-4cbe-9d9d-47aed4666d31 Q3 FLORIDA STATE UNIVERSITY 14952 FLORIDA STATE UNIVERSITY 2024 third_quarter MED FY 2025 Labor HHS Education Appropriations Act - NIH (NINDS) HOUSE OF REPRESENTATIVES,SENATE   38000 0 0 2024-10-02T14:25:32-04:00
3232106 REPUBLIC CONSULTING, LLC 5fc1df71-9268-4dc6-8341-726e03734bf0 Q3 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2024 third_quarter MED Monitor Health Data Policy. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2024-10-02T16:03:39-04:00
3232209 WATKINS & EAGER PLLC 43bb3a80-80bd-4ba6-8aa2-00d2bdb19c60 Q3 WATKINS & EAGER PLLC 401104403 NATIONAL FRAGILE X FOUNDATION 2024 third_quarter MED Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2024-10-03T10:39:46-04:00
3232234 AMERICAN COLLEGE OF CLINICAL PHARMACY 41da2eef-7e12-4553-98b8-76dbc47f668c Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2024 third_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2024-10-03T11:00:22-04:00
3232244 MARSHFIELD CLINIC HEALTH SYSTEM d398a8c7-7a25-4d73-9ede-b1542fc8a84a Q3 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2024 third_quarter MED research support, agriculture, farm safety, child care and agriculture communities HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2024-10-03T11:05:37-04:00
3232263 THE HARRIS FIRM a3049516-3add-45b9-8719-58d8f411e166 Q3 THE HARRIS FIRM 68376 HOLISTIC INDUSTRIES INC. 2024 third_quarter MED Issues pertaining to cannabis CSA scheduling. Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE 50000   0 0 2024-10-03T11:16:10-04:00
3232272 THE NEW ENGLAND COUNCIL 07e35fc5-cc41-4f4b-a05e-fd4c872a2c94 Q3 THE NEW ENGLAND COUNCIL 29106 NEW ENGLAND COUNCIL 2024 third_quarter MED HR 5539 - Optimizing Research Progress Hope and New Cures Act (OPRHAN Cures Act) HOUSE OF REPRESENTATIVES   5000 0 0 2024-10-03T11:30:42-04:00
3232328 FEDERAL SOLUTIONS, LLC af041761-8026-4e75-b1ca-177410fb53a3 Q3 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2024 third_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-10-03T14:02:34-04:00
3232347 DREXEL UNIVERSITY f4755106-b877-432a-9bf4-527b35c00c3a Q3 DREXEL UNIVERSITY 40032273 DREXEL UNIVERSITY 2024 third_quarter MED Advocacy around Medicaid reimbursements for high Medicaid medical facilities HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2024-10-03T15:09:04-04:00
3232405 2359 STRATEGIES dd0f4f46-dcce-4e2e-87e7-fb9ecb0a5bca Q3 2359 STRATEGIES 401106114 TRAVERE THERAPEUTICS 2024 third_quarter MED Rare kidney disease HOUSE OF REPRESENTATIVES,SENATE 12000   0 0 2024-10-03T18:25:31-04:00
3232469 FRANCIS EDWARD & CRONIN, INC. 2d947b19-76b0-43b8-921b-17d69a18a241 Q3 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2024 third_quarter MED Legislation related to Alzheimer's disease research Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2024-10-04T09:39:28-04:00
3232904 MASON STREET CONSULTING, LLC 83670047-0f44-4a43-918b-22dd6caed2d1 Q3 MASON STREET CONSULTING, LLC 401105150 PERIMETER MEDICAL IMAGING 2024 third_quarter MED Advanced Research Projects Agency for Health (ARPA-H). Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2024-10-07T06:23:28-04:00
3233113 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) a5007714-6789-4c90-95cc-65b6057fa8e2 Q3 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 401103161 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 2024 third_quarter MED NONE     10000 0 0 2024-10-07T12:58:29-04:00
3234012 IMPACT MANAGEMENT GROUP 4f29570d-925c-42b5-bceb-e72057c0ae73 Q3 IMPACT MANAGEMENT GROUP 401104137 ARKANSAS RESEARCH ALLIANCE 2024 third_quarter MED On behalf of client support continued and future funding for clinical research programs in Arkansas HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-10-09T10:13:57-04:00
3234120 IMPACT MANAGEMENT GROUP 935c6b78-3abe-47a5-b3ab-a4b2e949bf7b Q3 IMPACT MANAGEMENT GROUP 401104137 CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC. 2024 third_quarter MED Supporting the passage of H.R. 3173 - Improving Seniors' Timely Access to Care Act of 2021 HOUSE OF REPRESENTATIVES     0 0 2024-10-09T12:11:34-04:00
3234268 COMPASS GOVERNMENT RELATIONS PARTNERS, LLC 46072976-131e-4f07-8ec4-cb42780296db Q3 COMPASS GOVERNMENT RELATIONS PARTNERS, LLC 401106533 COALITION FOR INNOVATIVE LABORATORY TESTING, INC. 2024 third_quarter MED Matters pertaining to the VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses; Docket No. FDA-2023-N-2177 (FDA's release of the Final Rule on LDTs       0 0 2024-10-09T14:49:38-04:00
3234776 OLD NORTH STRATEGIES, LLC f1f0014b-f661-46e9-88d4-fde4f5543f81 Q3 OLD NORTH STRATEGIES, LLC 401106174 EXELA PHARMA SCIENCES, LLC 2024 third_quarter MED supply chain & FDA issues HOUSE OF REPRESENTATIVES,SENATE 108000   0 0 2024-10-10T12:37:01-04:00
3234832 MANATT, PHELPS, AND PHILLIPS ebf75395-0eb2-493f-a5c3-58d8dce43c83 Q3 MANATT, PHELPS, AND PHILLIPS 23645 LOMA LINDA UNIVERSITY MEDICAL CENTER 2024 third_quarter MED Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF   140000   0 0 2024-10-10T13:47:04-04:00
3234837 MANATT, PHELPS, AND PHILLIPS a45d2e79-f00b-4bcb-8a32-b583d2dccd5a Q3 MANATT, PHELPS, AND PHILLIPS 23645 MEDISYS HEALTH NETWORK 2024 third_quarter MED Provider Relief and COVID funding and other healthcare issues; Community Project Funding   40000   0 0 2024-10-10T13:48:02-04:00
3234927 BEN BARNES GROUP LP 5629b4f0-dd87-41b6-ae74-fb246aa7e502 Q3 BEN BARNES GROUP LP 5415 HUNTSMAN CORPORATION 2024 third_quarter MED CMS Medicare HOUSE OF REPRESENTATIVES,SENATE 18750   0 0 2024-10-10T14:21:00-04:00
3234966 BEN BARNES GROUP LP 91e0fe40-acfb-4953-94c5-06380e72aad4 Q3 BEN BARNES GROUP LP 5415 CLENE NANOMEDICINE, INC. 2024 third_quarter MED ALS HOUSE OF REPRESENTATIVES,SENATE 150000   0 0 2024-10-10T14:35:12-04:00
3235255 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2e0c20ad-5639-46ec-acd5-dc1005bbcf36 Q3 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2970 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2024 third_quarter MED none     189000 0 0 2024-10-11T10:56:11-04:00
3235284 SQUIRE PATTON BOGGS 1ac1d82e-e157-4cf1-90c6-d90f4200468e Q3 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2024 third_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2024-10-11T11:11:34-04:00
3235691 AMERICAN SOCIETY OF ADDICTION MEDICINE b80e0033-79f6-4941-94ca-0010175f1419 Q3 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2024 third_quarter MED Advocated for increased FY25 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY25 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for at least $10.5 billion for HRSA programs in the FY 2025 Labor, Health and Human Services, Education, and Related Agencies appropriations bill. Advocated for passage of H.R. 7050 - the Substance Use Disorder Workforce Act of 2024, with a recommendation that the Senate include additional monetary incentives in the bill for physicians training as addiction specialists. Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for S. 1165/ HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Advocated for HR 3074/S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Advocated for the Residential Recovery for Seniors Act (H.R. 9232 / S. 4860). This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for various substance use di… Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   60000 0 0 2024-10-11T16:33:59-04:00
3235963 CORNERSTONE GOVERNMENT AFFAIRS, INC. 64d5163a-6881-4de7-8d71-b89588a2dfff Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 HAZELDEN BETTY FORD FOUNDATION 2024 third_quarter MED Educate key government stakeholders on Hazelden Betty Ford Foundation activities in support of substance use and mental health for US Service members and Veterans. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-10-12T15:50:14-04:00
3236059 TIBER CREEK GROUP 22cae3fb-6835-4a33-9da9-0bac3ff3ac86 Q3 TIBER CREEK GROUP 20744 JAZZ PHARMACEUTICALS 2024 third_quarter MED Issues related to cannabis research; Issues related to the FDA; Issues related to cannabis research at Health and Human Services. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-10-13T10:58:51-04:00
3236567 CHAMBER HILL STRATEGIES 1deaf557-3149-4a0f-913d-34dc8a867294 Q3 CHAMBER HILL STRATEGIES 400645947 SANFORD HEALTH 2024 third_quarter MED Issues impacting diagnostics including FDA regulation of laboratory developed tests; H.R.2369, VALID Act of 2023. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2024-10-14T11:50:38-04:00
3236590 CHAMBER HILL STRATEGIES 532d7c3f-36b8-4e88-86f2-bbfe95f3eb9e Q3 CHAMBER HILL STRATEGIES 400645947 MAYO COLLABORATIVE SERVICES, INC. 2024 third_quarter MED Issues impacting diagnostics including FDA regulation of laboratory developed tests; H.R.2369, the VALID Act of 2023; S. 1000/H.R. 2377, the Saving Access to Laboratory Services Act HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2024-10-14T12:03:39-04:00
3236811 MCDERMOTT+ LLC 339d5eb2-2660-4475-a5f3-f5e54f52cb9e Q3 MCDERMOTT+ LLC 401103287 VERILY LIFE SCIENCES LLC 2024 third_quarter MED Efforts relating to artificial intelligence, wastewater surveillance and drug and device innovation. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-10-14T13:35:20-04:00
3236916 THE DLM GROUP 291b2137-1a0e-4f60-b556-0c3cf35a00ed Q3 THE DLM GROUP 313794 GENESIS HEALTH CARE, INC. 2024 third_quarter MED no activity HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-10-14T14:09:00-04:00
3236931 WINNING STRATEGIES WASHINGTON 64573020-0b24-4600-8b2f-80ecb8e3536c Q3 WINNING STRATEGIES WASHINGTON 50796 DIABETES PATIENT ADVOCACY COALITION 2024 third_quarter MED Issues related to treatment of diabetes and support for diabetes patients HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-10-14T14:11:06-04:00
3236982 WINNING STRATEGIES WASHINGTON 59db301a-a355-4c47-8a5f-558511ca71f8 Q3 WINNING STRATEGIES WASHINGTON 50796 I AM ALS 2024 third_quarter MED Funding for ALS research in annual Defense, Ag, and Labor-HHS-Education Appropriations bills Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2024-10-14T14:31:59-04:00
3237025 RESOLUTE-DC e7da9a39-e368-4e17-8d77-ba84853b14b2 Q3 RESOLUTE-DC 401106654 MODEL MEDICINES 2024 third_quarter MED Introduce Model Medicines and how the company is innovating at the intersection of data science, biology and drug development. Health & Human Services, Dept of (HHS)     0 0 2024-10-14T14:53:18-04:00
3237179 CORNERSTONE GOVERNMENT AFFAIRS, INC. 998537b2-7dbf-422e-98c1-505aa5b36da1 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 2024 third_quarter MED Congressional outreach related to health care issues. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-10-14T15:45:34-04:00
3237202 EFB ADVOCACY, LLC 87f99668-72fa-44a7-a2c9-37f2815008d0 Q3 EFB ADVOCACY, LLC 401104430 UNITED FOR MEDICAL RESEARCH 2024 third_quarter MED Funding Issues related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-10-14T15:52:39-04:00
3237270 SQUIRE PATTON BOGGS f62f9a69-53f5-428b-b328-0b92ff535246 Q3 SQUIRE PATTON BOGGS 30906 LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. 2024 third_quarter MED Funding support for federally qualified health centers; reauthorization of programs   20000   0 0 2024-10-14T16:11:58-04:00
3237357 THE PETRIZZO GROUP, INC. 7bc28c7c-692a-48d0-9e77-cd83b9927d2f Q3 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2024 third_quarter MED Increased funding for pediatric medical research HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2024-10-14T18:58:13-04:00
3237367 THE PETRIZZO GROUP, INC. 9791cc6f-651c-4483-998c-77cdae2c20a8 Q3 THE PETRIZZO GROUP, INC. 305932 DYSAUTONOMIA INTERNATIONAL 2024 third_quarter MED Advocate for NIH research funding for dysautonomia disorders, specifically Postural Orthostatic Tachycardia Syndrome (POTS) and funding to examine the correlation between POTS and Long COVID. Supporting establishment of an infection associated chronic conditions office at the NIH to coordinate research. Asking for continued support for the Autonomic Medicine Section at the NIH. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 45000   0 0 2024-10-14T19:07:56-04:00
3237377 THE PETRIZZO GROUP, INC. 4b3f358f-b58d-4b43-8fbe-522fe90c2fc8 Q3 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2024 third_quarter MED Development and execution of initiatives involving multiple Omeros pipeline targets before the U.S. Government, including funding collaborations associated with COVID, Cancer, and addition within the Department of HHS, NIH, BARDA, and the White House. FDA Rare Disease Center of Excellence Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2024-10-14T19:25:01-04:00
3237460 CORNERSTONE GOVERNMENT AFFAIRS, INC. 37cf3fb0-fe3e-4a61-a106-135e772ed277 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 MMV MEDICINES FOR MALARIA VENTURE 2024 third_quarter MED The purpose was to increase funding for malaria research in the Department of Defense. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-10-14T22:22:22-04:00
3237497 CORNERSTONE GOVERNMENT AFFAIRS, INC. 5a4e667d-0b32-45d4-ac28-97a4d5f9e285 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 ADVANCED MATERIALS AND DEVICES, INC. 2024 third_quarter MED Educated key government stakeholders on AMADs products applicable to the military and supported appropriations requests. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-10-14T23:45:11-04:00
3237677 AMERICAN LUNG ASSOCIATION 103950fd-0c0f-46f7-91ab-e7d2171a5866 Q3 AMERICAN LUNG ASSOCIATION 2811 AMERICAN LUNG ASSOCIATION 2024 third_quarter MED Issues relating to the Presidents FY25 budget; Issues relating to FY25 appropriations; Issues relating to the Presidents FY26 budget; Issues related to asthma, COPD, influenza, lung cancer, pneumonia, pulmonary fibrosis, tuberculosis and other lung diseases; Issues related to NIH reorganization; Issues related to lung disease treatment, prevention and research; Issues related to COVID-19; Issues related to telehealth; Issues related to infrastructure; Issues related to supplemental oxygen; Issues related to health equity; Issues related to Cancer Moonshot; Issues related to CDC public health workforce and data modernization; Issues related to regulatory reform; H.R. 833 Stop the Wait Act; Issues related to Medicaid; ; HR 890 The Guidance Out of Darkness Act; S 791 The Guidance Out of Darkness Act;; HR 357 Ensuring Accountability in Agency Rulemaking; ; HR 7867 Renewing Efficiency in Government by Budgeting Act; HR 115 Midnight Rules Relief Act; HR 1602, Health Care Affordability Act of 2023; S. 8 Improving Health Insurance Affordability Act of 2023; HR 9029 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2025; H.R. 8774 Department of Defense Appropriations Act 2025; S. 4942 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; S 4921 Department of Defense Appropriations Act 2025; HR 890 Guidance out of Regulatory Darkness Act; HR 9747 Continuing Appropriations and Extensions Act, 2025; HR 9494 Continuing Appropriations and Other Matters Act 2025; H.R. 9774, Health Care Affordability Act of 2024; S. 5194, Health Care Affordability Act of 2024; S. 652 Safe Step Act; HR 2630 Safe Step Act Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   180000 0 0 2024-10-15T10:11:05-04:00
3237685 MCCARTHY STRATEGIC SOLUTIONS 869ca243-93d5-4112-9755-18256575ec28 Q3 MCCARTHY STRATEGIC SOLUTIONS 300936 INOTIV, INC. 2024 third_quarter MED Animal research models to biopharmaceuticals, academic and government research for realizing life saving medications HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-10-15T10:12:15-04:00
3238202 CORNERSTONE GOVERNMENT AFFAIRS, INC. db1e283b-cdd5-4e42-8415-34ceadd908be Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM 2024 third_quarter MED Educated key government stakeholders on the Medical Technology Enterprise Consortiums activities and partnership model in support of Servicemember health and readiness. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-10-15T13:06:53-04:00
3238250 CORNERSTONE GOVERNMENT AFFAIRS, INC. 67378b31-44e6-4ec1-98d0-62820146f642 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 NIRSENSE, LLC (FKA BIONICA LABS) 2024 third_quarter MED Educated key government stakeholders on NIRSenses activities and technologies in support of the Armed Forces and support Defense appropriations and authorization requests. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-10-15T13:22:31-04:00
3238500 CORNERSTONE GOVERNMENT AFFAIRS, INC. 4ccb9f79-c760-4110-bec7-26534d9f0797 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 SMITH & NEPHEW 2024 third_quarter MED Educated key government stakeholders on Smith+Nephew products applicable to the military and support appropriations requests. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-10-15T14:36:41-04:00
3238584 CORNERSTONE GOVERNMENT AFFAIRS, INC. 1ae66ac1-77ed-409b-825f-b232ae479143 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE GENEVA FOUNDATION 2024 third_quarter MED Educated key government stakeholders on The Geneva Foundations research and development activities in support of US Service members. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-10-15T14:53:21-04:00
3239075 F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES 5e50836f-7f39-4eb3-b4d8-251d03179838 Q3 F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES 18411 F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES 2024 third_quarter MED Clinical Lab Fee Schedule H.R. 2377 and S. 1000. Saving Access to Laboratory Services Act (SALSA) and H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023 FY25 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2024-10-15T17:12:41-04:00
3239197 MICHAEL N. MCCARTY LAW OFFICE PLLC 8daa35e6-f177-414e-bbea-c5f891e0aa1e Q3 MICHAEL N. MCCARTY LAW OFFICE PLLC 401104300 AMERICAN MEDICAL TECHNOLOGISTS 2024 third_quarter MED Legislation to regulate laboratory-developed in vitro diagnostic (IVD) tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to the Medical Laboratory Personnel Shortage Relief Act of 2024 (H.R.9849); support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477). HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-10-15T18:32:32-04:00
3239428 VENABLE LLP 357558ac-418c-4423-9088-97067e3ebbae Q3 VENABLE LLP 39941 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2024 third_quarter MED Senate Malaria and National Tropical Diseases (NTD) Caucus H. Res 126 /S. Res 264 Supporting US role in Gavi, The Vaccine Alliance NIH reform proposals HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-10-16T09:25:56-04:00
3239443 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) cde3b0b3-4766-484e-b98e-c1227cf8c85a Q3 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 INTUITIVE SURGICAL, INC. 2024 third_quarter MED Lobbying related to health care issues. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-10-16T09:34:02-04:00
3239490 UNIVERSITY OF IOWA 37a1cfa6-d120-4b43-a69e-5b99aab72075 Q3 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2024 third_quarter MED N.A. HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2024-10-16T09:47:58-04:00
3239642 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) ec1641e6-47ed-4b96-9371-5ea3be5c49a9 Q3 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2024 third_quarter MED * On July 7, ADLM joined with other healthcare providers in supporting a resolution to employ the Congressional Review Act as it pertains to the FDAs Proposed Rule, Docket No. FDA-2023-N-2177, Medical Devices: Laboratory Developed Tests. * On September 5, ADLM wrote to House and Senate leaders providing survey results indicating the clinical laboratories will have problems complying with the FDA final rule regulating LDTs. * On August 15 and September 4, ADLM initiated grassroots campaigns urging House and Senate members to support future legislative efforts to revoke the FDA LDT final rule. * On September 10th, ADLM participating in Rare Disease Congress Caucus outlining concern about FDA LDT final rule. HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2024-10-16T10:32:59-04:00
3239671 COVINGTON & BURLING LLP 8af3987b-07b1-47cd-a274-3b11239cea3a Q3 COVINGTON & BURLING LLP 11195 AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA) 2024 third_quarter MED Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation; VALID Act (H.R. 2369) SENATE 40000   0 0 2024-10-16T10:39:44-04:00
3239892 COMMONWEALTH POLICY SOLUTIONS a92a8c72-7bbf-40a1-bfe4-795cb990c326 Q3 COMMONWEALTH POLICY SOLUTIONS 401105004 RARE ACCESS ACTION PROJECT 2024 third_quarter MED Medicare and Medicaid rare diseases HOUSE OF REPRESENTATIVES,SENATE 36000   0 0 2024-10-16T11:42:12-04:00
3240080 STANFORD UNIVERSITY 5899d7a1-40cc-4102-996a-d54b8e74f6b7 Q3 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2024 third_quarter MED HR 2389 Resident Physician Shortage Reduction Act of 2023 Antiviral drug research / Antiviral Drug Discovery Centers HOUSE OF REPRESENTATIVES,SENATE   110000 0 0 2024-10-16T12:16:34-04:00
3240168 PONTIS PARTNERS, LLC 13bdd63f-cd4d-4164-b4dd-f1d9be5f59e4 Q3 PONTIS PARTNERS, LLC 401107566 KIDNEY TRANSPLANT COLLABORATIVE 2024 third_quarter MED Enactment of The Living Organ Volunteer Engagement (LOVE) Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-10-16T12:39:50-04:00
3240522 O'NEILL AND ASSOCIATES 313f4c56-5088-4dd1-ab61-5ffe59dad829 Q3 O'NEILL AND ASSOCIATES 73134 POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) 2024 third_quarter MED Healthcare, Medical HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2024-10-16T14:15:03-04:00
3240700 O'NEILL AND ASSOCIATES e6ed3c05-ce0d-4583-beeb-b5712de57291 Q3 O'NEILL AND ASSOCIATES 73134 CARIBBEAN CONNECTIONS EQUITABLE RESEARCH 2024 third_quarter MED Funding HOUSE OF REPRESENTATIVES,SENATE 25500   0 0 2024-10-16T14:47:59-04:00
3240806 THE LIVINGSTON GROUP, LLC d846e581-f005-4215-828a-d318a6c3bcc4 Q3 THE LIVINGSTON GROUP, LLC 49635 INNOVATIVE VACCINE TECHNOLOGIES 2024 third_quarter MED FY2025 appropriations for the development of a synthetic vaccine HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-10-16T15:10:02-04:00
3241117 CORNERSTONE GOVERNMENT AFFAIRS, INC. b567681d-f194-47eb-b93f-a80faad037c4 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THERADAPTIVE, INC. 2024 third_quarter MED Educated key government stakeholders on Theradaptives products applicable to the military and support appropriations requests. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-10-16T16:01:22-04:00
3241291 NATIONAL MULTIPLE SCLEROSIS SOCIETY e160f404-86c8-4e9a-86d1-1f4db4e84c29 Q3 NATIONAL MULTIPLE SCLEROSIS SOCIETY 69674 NATIONAL MULTIPLE SCLEROSIS SOCIETY 2024 third_quarter MED S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage The Biosimilar Red Tape Elimination Act, monitor legislation U.S. HOUSE OF REPRESENTATIVES, U.S. Senate, Natl Institutes of Health (NIH), Defense - Dept of (DOD), Food & Drug Administration (FDA), Veterans Affairs - Dept of (VA) Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   60810 0 0 2024-10-16T16:25:08-04:00
3241452 CORNERSTONE GOVERNMENT AFFAIRS, INC. 56c75e89-93bf-4c77-89f4-c64fb3b29166 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 AMERICAN SOCIETY FOR RADIATION ONCOLOGY 2024 third_quarter MED Discussions regarding patient access to radiation oncology. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES 50000   0 0 2024-10-16T16:59:54-04:00
3241741 CORNERSTONE GOVERNMENT AFFAIRS, INC. 0214a8ef-edde-45da-b9b3-e69e525464e4 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 BIONTECH US INC. 2024 third_quarter MED Educated policymakers on BioNTech's federally funded research and development activities. HOUSE OF REPRESENTATIVES,SENATE 110000   0 0 2024-10-16T23:32:23-04:00
3241745 CORNERSTONE GOVERNMENT AFFAIRS, INC. 9b9522da-6200-4c67-9554-923905990fe4 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 LUMEN BIOSCIENCE, INC. 2024 third_quarter MED Educated policymakers and key government stakeholders on Lumens research and development activities in support of US Service members and Defense appropriations. HOUSE OF REPRESENTATIVES 30000   0 0 2024-10-16T23:43:51-04:00
3241820 BALLARD PARTNERS fba8308b-a4ef-4f11-bb91-d9da1189f397 Q3 BALLARD PARTNERS 401104288 BRAIN ANEURYSM FOUNDATION 2024 third_quarter MED To promote and advocate for S. 895/HR. 902. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-10-17T07:29:27-04:00
3241876 BALLARD PARTNERS b8dfe317-a1fb-4a51-898c-c4dce913abde Q3 BALLARD PARTNERS 401104288 EXTHERA MEDICAL CORPORATION 2024 third_quarter MED Guidance and advocacy related to procurement approval from the VA and DoD health systems. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2024-10-17T08:46:00-04:00
3241879 BALLARD PARTNERS 48875e21-8ed8-4f19-98db-408853fa67d4 Q3 BALLARD PARTNERS 401104288 EXTREMITY CARE LLC 2024 third_quarter MED Promoting the advancement of healthcare technology. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 130000   0 0 2024-10-17T08:54:56-04:00
3242138 IPOLICY SOLUTIONS 81798433-6752-4449-ab3f-64d58a7b7a15 Q3 IPOLICY SOLUTIONS 401105127 ASSOCIATION FOR MOLECULAR PATHOLOGY 2024 third_quarter MED No bill #: legislation to modernize CLIA H.R.2369 - VALID Act of 2023 FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests" HOUSE OF REPRESENTATIVES,SENATE 70500   0 0 2024-10-17T10:14:36-04:00
3242310 THE CONSILIO GROUP e37b0962-b47e-4c5a-ae60-e6cc2eb6f436 Q3 THE CONSILIO GROUP 400374717 DETECTACHEM 2024 third_quarter MED Colorimetric explosive and narcotic detection capabilities Air Force, Dept of,Defense, Dept of (DOD),Education, Dept of,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,White House Office 16500   0 0 2024-10-17T10:42:22-04:00
3242387 COMMONWEALTH STRATEGIC PARTNERS, LLC a4080582-4de7-42f5-9785-b4f199d9aa48 Q3 COMMONWEALTH STRATEGIC PARTNERS, LLC 401103486 PEOPLE FOR THE ETHICAL TREATMENT OF ANIMALS (PETA) 2024 third_quarter MED Issues related to animal testing and experimentation, specifically H.R. 4757 Cease Animal Research Grants Overseas (CARGO) Act. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-10-17T10:49:33-04:00
3242405 COMMONWEALTH STRATEGIC PARTNERS, LLC 9b053d0e-7605-4493-a0a2-808cc4e57d6b Q3 COMMONWEALTH STRATEGIC PARTNERS, LLC 401103486 AMERICAN ASSOCIATION OF SUICIDOLOGY 2024 third_quarter MED Support policies and research for suicide awareness, training, outreach, and prevention, including but not limited to robust HHS funding and improvements to the 988 program HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-10-17T10:50:37-04:00
3242491 AMERICAN CLINICAL LABORATORY ASSN 23cc99e2-d1b0-40f4-8fb8-f96c9d1789c5 Q3 AMERICAN CLINICAL LABORATORY ASSN 1923 AMERICAN CLINICAL LABORATORY ASSN 2024 third_quarter MED Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; FY 2024 budget and appropriations processes, artificial intelligence in laboratory services; public-private sector testing response in general and specific to Influenza A (H5) avian flu, monkeypox and oropouche; H.R. 2377/S. 1000, Saving Access to Laboratory Services Act; H.R. 8818, American Privacy Rights Act of 2024; H.R. 8702/S. 4532, Improving Seniors Timely Access to Care Act; and H.R. 2369, the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2023. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Security Council (NSC),SENATE,White House Office   540000 0 0 2024-10-17T11:00:12-04:00
3242525 FONTENOT HEALTH POLICY LLC dcc20774-85a6-4225-9ecb-0dc354ea9c2b Q3 FONTENOT HEALTH POLICY LLC 401107703 ORGANIZE DBA ORGANIZE ACTION NETWORK 2024 third_quarter MED Organ Procurement reforms; Revisions to the Outcome Measure Requirements for Organ Procurement Organizations; Final Rule (42 CFR, Part 486); Organ Procurement Organizations Conditions of Coverage; S. 1688/H.R. 2544 Securing the U.S. Organ Procurement and Transplantation Network Act HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-10-17T11:01:50-04:00
3242666 IMPACT HEALTH POLICY PARTNERS 74277c65-ca95-4473-971b-3b5d5742607f Q3 IMPACT HEALTH POLICY PARTNERS 401104696 ABBOTT LABORATORIES 2024 third_quarter MED Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-10-17T11:13:24-04:00
3242703 IMPACT HEALTH POLICY PARTNERS 679e795c-a211-44a9-9085-c795614592ce Q3 IMPACT HEALTH POLICY PARTNERS 401104696 CHILDREN'S HOSPITAL COLORADO 2024 third_quarter MED Issues related to pediatric research and children's hospital graduate medical education. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-10-17T11:17:08-04:00
3242815 CAPITOL COUNSEL LLC 5134d2c5-1057-45ae-ae07-04c6c83bfaff Q3 CAPITOL COUNSEL LLC 313715 BLUE EARTH DIAGNOSTICS, INC. 2024 third_quarter MED To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-10-17T11:32:46-04:00
3243016 TENAGRITY SOLUTIONS, LLC 3330d236-72ee-43d9-aeaa-f30d435f26c7 Q3 TENAGRITY SOLUTIONS, LLC 401107856 KARDIOGENICS, INC. 2024 third_quarter MED Discussions with congressional offices and DoD re: client and how their product and work (including how they can help with defense); meetings with FDA officials re: approval for client's product Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-10-17T11:54:37-04:00
3243023 CAPITOL COUNSEL LLC 2d0d78e7-c653-4f44-bc03-b76d431b328b Q3 CAPITOL COUNSEL LLC 313715 EMD SERONO, INC. 2024 third_quarter MED Issues regarding the availability and pricing of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-10-17T11:56:09-04:00
3243039 CAPITOL COUNSEL LLC 00cf8694-aa39-4095-89a6-01345b583c08 Q3 CAPITOL COUNSEL LLC 313715 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 2024 third_quarter MED Monitor health and tax legislation pertaining to the biotechnology industry. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-10-17T11:58:31-04:00
3243236 NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH 3be7e104-cb33-4233-9f61-1a7f07009b13 Q3 NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH 26557 NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH 2024 third_quarter MED Support funding for biomedical research HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2024-10-17T12:30:37-04:00
3243249 BLUEBIRD STRATEGIES 101d2563-b0db-46a5-bb61-b5419cb688d1 Q3 BLUEBIRD STRATEGIES 401105447 MYOTONIC 2024 third_quarter MED Increasing funding for Myotonic Dystrophy research. Fiscal Year 2025 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-10-17T12:36:28-04:00
3243281 BLUEBIRD STRATEGIES fcf6c1f9-b36e-46ee-bf2e-8352f31d6c8d Q3 BLUEBIRD STRATEGIES 401105447 NCATS ALLIANCE 2024 third_quarter MED FY2025 NCATS funding HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2024-10-17T12:43:07-04:00
3243298 BLUEBIRD STRATEGIES fc0e3b0e-3df5-4e67-9042-7e2e114539f8 3T BLUEBIRD STRATEGIES 401105447 MYRIAD GENETICS, INC. 2024 third_quarter MED Legislation to regulate clinical testing/labs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 1 2024-10-17T12:47:02-04:00
3243429 ISEMAN & ASSOCIATES LLC da94157a-cad7-487a-821c-035306e8c064 Q3 ISEMAN & ASSOCIATES LLC 401103582 TICHENOR VENTURES, LLC 2024 third_quarter MED Monitoring biotech legislation HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-10-17T13:13:43-04:00
3243907 CORNERSTONE GOVERNMENT AFFAIRS, INC. 76ffcd59-1cc0-45f8-8f41-ba44f6d7e5e6 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 VOCXI HEALTH 2024 third_quarter MED Educated policymakers and key government stakeholders on VOCxi Health research and development activities in support of US Service members and Defense appropriations. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-10-17T14:14:22-04:00
3243963 FORBES-TATE 649b0dcf-a2ce-4083-8313-5425879d30e6 Q3 FORBES-TATE 400976792 AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION 2024 third_quarter MED Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; H.R. 6371 - Provider Reimbursement Stability Act of 2023; S. 4935 - Physician Fee Stabilization Act. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-10-17T14:20:19-04:00
3244066 COVINGTON & BURLING LLP 40ccf079-b8e8-4ac1-9581-f4caf7c10585 Q3 COVINGTON & BURLING LLP 11195 RWE ALLIANCE INC. 2024 third_quarter MED Real-world health data and analytics policy. HOUSE OF REPRESENTATIVES 30000   0 0 2024-10-17T14:26:46-04:00
3244231 FORBES-TATE 2135d0ea-37ea-4b65-9a02-0feb6c2dd812 Q3 FORBES-TATE 400976792 AMGEN USA, INC. 2024 third_quarter MED Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2024-10-17T14:39:04-04:00
3244280 WILLIAMS AND JENSEN, PLLC e1508e4b-6cbd-43b5-bea7-c16e0545e712 Q3 WILLIAMS AND JENSEN, PLLC 41454 RIVER REGION PSYCHIATRY ASSOCIATES 2024 third_quarter MED Work to educate Republican and Democrat members on the unique model of RRPA for providing psychiatric care and developing potential care pilot programs in Medicaid and/or CMMI. HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 30000   0 0 2024-10-17T14:46:03-04:00
3244432 CORNERSTONE GOVERNMENT AFFAIRS, INC. 0b7b8722-2560-48d1-b0b5-fa240334bcb6 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE REGENTS OF THE UNIVERSITY OF COLORADO OBO UNIVERSITY OF COLORADO ANSCHUTZ 2024 third_quarter MED Educated key government stakeholders on the University's medical capabilities in areas applicable to military health and readiness. Supported Defense authorizations and appropriations. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-10-17T14:56:48-04:00
3244537 AMERICAN PHYSICAL THERAPY ASSOCIATION 3cfdca8b-b864-4d58-bfbb-ac0895e124cc Q3 AMERICAN PHYSICAL THERAPY ASSOCIATION 3093 AMERICAN PHYSICAL THERAPY ASSOCIATION 2024 third_quarter MED NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding PT role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   240412 0 0 2024-10-17T15:03:15-04:00
3244565 TWENTY-FIRST CENTURY GROUP, INC. d9cf9457-b2d5-4000-90ec-275b35df483d Q3 TWENTY-FIRST CENTURY GROUP, INC. 38687 NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX) 2024 third_quarter MED Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD. HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-10-17T15:06:34-04:00
3244689 CORNERSTONE GOVERNMENT AFFAIRS, INC. cf11ab5c-24ec-4d99-bcb6-1a0c2d8e92cd Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 WASHINGTON STATE UNIVERSITY 2024 third_quarter MED Educated key government stakeholders on WSU's research and development in support of US Service Members, support Defense appropriations and medical research programs for infectious diseases and global health within NIH HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-10-17T15:16:07-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2290.35ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API